Literature DB >> 15208665

Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer.

Zhihong Shan1, Tracy Parker, Jonathan S Wiest.   

Abstract

Loss of heterozygosity (LOH) studies indicate that genetic alterations of chromosome 9p occur in numerous tumor types, suggesting the presence of tumor suppressor genes (TSGs) on chromosome 9p critical in carcinogenesis. Our previous LOH analyses in primary lung tumors led us to propose that chromosome 9p harbors other TSGs important in lung tumorigenesis. In this study, 30 non-small-cell lung cancer and 12 small-cell lung cancer cell lines were screened with 55 markers to identify new regions of homozygous deletion (HD) on chromosome 9p. Three novel noncontiguous homozygously deleted regions were detected and ranged in size from 840 kb to 7.4 Mb. One gene identified in the deletion at D9S126, TUSC1 (tumor suppressor candidate 1), is an intronless gene. Multiplex polymerase chain reaction and Southern blot confirmed the HD of TUSC1. Northern blot analysis of TUSC1 demonstrated two transcripts of approximately 2 and 1.5 kb that are likely generated by alternative polyadenylation signals. Both transcripts are expressed in several human tissues and share an open-reading frame encoding a peptide of 209 amino acids. Analysing cell line cDNAs by reverse transcriptase (RT)-PCR demonstrated downregulation of TUSC1 in cell lines with or without HDs, suggesting that TUSC1 may play a role in lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208665      PMCID: PMC3449089          DOI: 10.1038/sj.onc.1207857

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene.

Authors:  L J Mead; M T Gillespie; J Y Hung; U S Rane; K C Rayeroux; L B Irving; L J Campbell
Journal:  Int J Cancer       Date:  1997-04-10       Impact factor: 7.396

2.  Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.

Authors:  S Takeuchi; M Koike; T Seriu; C R Bartram; J Slater; S Park; I Miyoshi; H P Koeffler
Journal:  Leukemia       Date:  1997-10       Impact factor: 11.528

3.  Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.

Authors:  K Hamada; T Kohno; M Takahashi; M Yamazaki; M Yamazaki; H Tashiro; C Sugawara; S Ohwada; Y Sekido; J D Minna; J Yokota
Journal:  Genes Chromosomes Cancer       Date:  2000-03       Impact factor: 5.006

4.  Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.

Authors:  J S Wiest; W A Franklin; J T Otstot; K Forbey; M Varella-Garcia; K Rao; H Drabkin; R Gemmill; S Ahrent; D Sidransky; G Saccomanno; J W Fountain; M W Anderson
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

5.  CDKN2A/p16 is inactivated in most melanoma cell lines.

Authors:  M Castellano; P M Pollock; M K Walters; L E Sparrow; L M Down; B G Gabrielli; P G Parsons; N K Hayward
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

Review 6.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

Authors:  S B Baylin; J G Herman
Journal:  Trends Genet       Date:  2000-04       Impact factor: 11.639

Review 7.  Alterations in DNA methylation: a fundamental aspect of neoplasia.

Authors:  S B Baylin; J G Herman; J R Graff; P M Vertino; J P Issa
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

Review 8.  Cancer epigenetics comes of age.

Authors:  P A Jones; P W Laird
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

9.  Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma.

Authors:  K Hamada; T Kohno; M Kawanishi; S Ohwada; J Yokota
Journal:  Genes Chromosomes Cancer       Date:  1998-07       Impact factor: 5.006

10.  Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.

Authors:  J C Sheu; Y W Lin; H C Chou; G T Huang; H S Lee; Y H Lin; S Y Huang; C H Chen; J T Wang; P H Lee; J T Lin; F J Lu; D S Chen
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more
  14 in total

1.  A genome-wide study on the perception of the odorants androstenone and galaxolide.

Authors:  Antti Knaapila; Gu Zhu; Sarah E Medland; Charles J Wysocki; Grant W Montgomery; Nicholas G Martin; Margaret J Wright; Danielle R Reed
Journal:  Chem Senses       Date:  2012-02-23       Impact factor: 3.160

2.  A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.

Authors:  Sha Tao; Zhong Wang; Junjie Feng; Fang-Chi Hsu; Guangfu Jin; Seong-Tae Kim; Zheng Zhang; Henrik Gronberg; Lilly S Zheng; William B Isaacs; Jianfeng Xu; Jielin Sun
Journal:  Carcinogenesis       Date:  2012-01-04       Impact factor: 4.944

3.  Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Xueying Liang; Ruth M Pfeiffer; William Wheeler; Dennis Maeder; Laurie Burdette; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

4.  Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.

Authors:  K Laud; C Marian; M F Avril; M Barrois; A Chompret; A M Goldstein; M A Tucker; P A Clark; G Peters; V Chaudru; F Demenais; A Spatz; M W Smith; G M Lenoir; B Bressac-de Paillerets
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

5.  Tumor Suppressor Candidate 1 Suppresses Cell Growth and Predicts Better Survival in Glioblastoma.

Authors:  Rui Zhang; Wan Yu; Guanyu Liang; Zhanjun Jia; Zhengxin Chen; Lin Zhao; Yongsheng Yuan; Xiaobin Zhou; Daqian Li; Shuying Shen; Ning Liu; Aihua Zhang; Huibo Wang; Gang Wang
Journal:  Cell Mol Neurobiol       Date:  2016-02-20       Impact factor: 5.046

6.  Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia.

Authors:  Ina Radtke; Charles G Mullighan; Masami Ishii; Xiaoping Su; Jinjun Cheng; Jing Ma; Ramapriya Ganti; Zhongling Cai; Salil Goorha; Stanley B Pounds; Xueyuan Cao; Caroline Obert; Jianling Armstrong; Jinghui Zhang; Guangchun Song; Raul C Ribeiro; Jeffrey E Rubnitz; Susana C Raimondi; Sheila A Shurtleff; James R Downing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

7.  Association of TUSC1 and DPF3 gene polymorphisms with male infertility.

Authors:  Youichi Sato; Chise Hasegawa; Atsushi Tajima; Shiari Nozawa; Miki Yoshiike; Eitetsue Koh; Jiro Kanaya; Mikio Namiki; Kiyomi Matsumiya; Akira Tsujimura; Kiyoshi Komatsu; Naoki Itoh; Jiro Eguchi; Aiko Yamauchi; Teruaki Iwamoto
Journal:  J Assist Reprod Genet       Date:  2017-10-03       Impact factor: 3.412

8.  Elite model for the generation of induced pluripotent cancer cells (iPCs).

Authors:  Jason Lai; Chiou Mee Kong; Dashayini Mahalingam; Xiaojin Xie; Xueying Wang
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.

Authors:  Sara Parsa; Ana Ortega-Molina; Hsia-Yuan Ying; Man Jiang; Matt Teater; Jiahui Wang; Chunying Zhao; Ed Reznik; Joyce P Pasion; David Kuo; Prathibha Mohan; Shenqiu Wang; Jeannie M Camarillo; Paul M Thomas; Neeraj Jain; Javier Garcia-Bermudez; Byoung-Kyu Cho; Wayne Tam; Neil L Kelleher; Nicholas Socci; Ahmet Dogan; Elisa De Stanchina; Giovanni Ciriello; Michael R Green; Sheng Li; Kivanc Birsoy; Ari M Melnick; Hans-Guido Wendel
Journal:  Nat Cancer       Date:  2020-06-22

10.  TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo.

Authors:  Zhihong Shan; Abbas Shakoori; Sohrab Bodaghi; Paul Goldsmith; Jen Jin; Jonathan S Wiest
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.